Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$55.95 -0.71 (-1.25%)
At close: Oct 23, 2026 · 4:00 PM EDT

Biomarin Pharmaceutical (BMRN) Sale and Maturity of Investments (2009 - 2026)

Updated

Analysis

Biomarin Pharmaceutical (BMRN) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Biomarin Pharmaceutical 10.83 Bn 4.69 Bn 786.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 767.28 Mn
Dec 31, 2025 43.25 Mn
Sep 30, 2025 98.81 Mn
Jun 30, 2025 117.93 Mn
Mar 31, 2025 77.80 Mn
Dec 31, 2024 154.58 Mn
Sep 30, 2024 160.79 Mn
Jun 30, 2024 186.12 Mn
Mar 31, 2024 131.53 Mn
Dec 31, 2023 113.19 Mn
Sep 30, 2023 260.61 Mn
Jun 30, 2023 275.95 Mn
Mar 31, 2023 215.12 Mn
Dec 31, 2022 142.75 Mn
Sep 30, 2022 165.65 Mn
Jun 30, 2022 155.78 Mn
Mar 31, 2022 155.82 Mn
Dec 31, 2021 188.94 Mn
Sep 30, 2021 153.17 Mn
Jun 30, 2021 154.30 Mn
API Access

Biomarin Pharmaceutical Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=BMRN&period=max&api_key=YOUR_API_KEY